Are you being measured on the right things? Most MSL teams aren't.

In the latest ACMA Medical Affairs x MSL Power Play Series, ACMA founder Will Soliman sits down with Alicia O'Connor, Head of Field Medical, Rare Neurology at Lundbeck, to tackle one of medical affairs' hottest debates: MSL metrics. Alicia has built and led high-performing field medical teams across big pharma and biotech, from oncology, diagnostics, and cell therapy to rare disease, and she brings a refreshingly honest, fit-for-purpose take on what really measures MSL success.

Together they unpack:

• The KPIs that matter most for MSLs, and how they've evolved

• Quantitative vs. qualitative metrics in large pharma vs. small rare disease teams

• What a truly high-quality scientific exchange with a KOL looks like

• How to turn field insights into value the whole organization sees

• How to link MSL performance metrics to medical affairs and corporate goals

You'll find out:

• Why counting KOL visits can be a misleading "surrogate marker" for MSL success

• The low-tech insights tool Alicia defends that sparked debate on LinkedIn

• Why Manhattan and rural territories should never be judged the same way

• The one metric Alicia says you can't put a monthly quota on

• How to get noticed when you want to move up to MSL manager

• How to break into an MSL role with no industry experience

• How a solo MSL at a startup, with no manager, can prove their value

Whether you're a new MSL, a field medical leader building a team, or a pharmacist, PhD, MD, or clinician breaking into the pharmaceutical industry, this episode shows you how success is really measured in medical affairs.

Follow the ACMA Medical Affairs x MSL Power Play Series so you never miss an episode, and share this one with an MSL colleague or field medical leader.

Exclusive listener offer: Get 30% OFF ACMA's premier Medical Science Liaison board certification programs, the Board Certified Medical Affairs Specialist (BCMAS) and the Medical Science Liaison Board Certified Biologics and Biosimilars Specialist (BCBBS), rated #1 by Industry Insiders. Use code at checkout: PODCAST30

Don't forget to "Like" and "Follow" to get the latest episodes

You Can Follow Will Soliman on:

• • LinkedIn
  • willsoliman.com
• • The Will Soliman Podcast on Spotify

• 
  

  Follow Accreditation Council for Medical Affairs (ACMA)

  • LinkedIn

  
  

  
  

  
  

  Keywords: Medical Affairs, Medical Science Liaison, MSL, MSL metrics, MSL KPIs, field medical, field medical leadership, MSL performance, scientific exchange, KOL engagement, medical insights, rare disease, rare neurology, neurology, cell therapy, oncology, MSL manager, how to become an MSL, MSL career, pharma careers, biotech careers, BCMAS, BCBBS, board certification, ACMA